(Q33658701)

28 July 2017

1 reference

25 October 2022

Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature (English)

1 reference

interstitial lung disease

28 July 2017

1 reference

27 October 2020

1 reference

16 November 2019

1 reference

20 November 2019

1 reference

1 reference

20 July 2020

1 reference

27 October 2020

Serena Slavenburg

1

1 reference

28 July 2017

Yvonne F Heijdra

series ordinal

2

1 reference

28 July 2017

Joost P H Drenth

series ordinal

3

1 reference

28 July 2017

28 April 2009

1 reference

Digestive Diseases and Sciences

28 July 2017

1 March 2010

11 references

23 March 2019

21 March 2019

22 June 2019

1 October 2019

7 November 2019

16 November 2019

20 November 2019

1 July 2020

20 July 2020

27 October 2020

25 October 2022

12 references

28 July 2017

23 March 2019

21 March 2019

22 June 2019

1 October 2019

7 November 2019

16 November 2019

20 November 2019

1 July 2020

20 July 2020

27 October 2020

25 October 2022

55

1 reference

28 July 2017

3

1 reference

28 July 2017

579-585

1 reference

Creative Commons Attribution-NonCommercial

28 July 2017

1 reference

25 October 2022

https://scigraph.springernature.com/pub.10.1007/s10620-009-0797-1

0 references

cites work

Interstitial pneumonitis associated with pegylated interferon alpha-2b therapy for chronic hepatitis C: case report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Peginterferon and ribavirin for chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Diagnosis, management, and treatment of hepatitis C

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Side effects of therapy of hepatitis C and their management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Hepatitis C virus infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

A perspective on the clinical effectiveness and tolerance of interferon-alpha

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Side effects of high-dose interferon therapy for chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Interstitial pneumonitis and interferon-alfa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Seizures associated with low-dose alpha-interferon

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

[Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C].

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Consensus interferon induced interstitial pneumonitis in a patient with HCV.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Interstitial pneumonia recurrence during chronic hepatitis C treatment.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

Interstitial pneumonitis during combination therapy with interferon-alpha and ribavirin in a patient with chronic Hepatitis C.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822957

[Induced interstitial pneumonitis: role of pegylated interferon alpha 2b]

30 October 2018

1 reference

12 December 2020

Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C

1 reference

12 December 2020

Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis C

1 reference

12 December 2020

Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients

1 reference

12 December 2020

10.1007/S10620-009-0797-1

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference